FDA Investigator Sarah Adella Fave
Sarah Adella Fave has inspections in 2 countries as of 17 Feb 2022. Sarah Adella Fave has collaborated with a combined 1350 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
17 Feb 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adetutu M Gidado,
Alberto A Viciedo,
Allen Lou,
Amy L Singer,
Amy M Cramer,
Ana S Cabrera,
Ann Marie Montemurro,
Annemarie Bodnar,
Atul J Agrawal,
Barbara J Wilimczyk,
Barbara Jwilimczyk Macri,
Barbara L Rellahan, PhD,
Cara M Minelli,
Constantin Y Philopoulos,
Daniel J Grabicki,
Dawn L Wydner,
Deborah B Nixon,
Doreen P Gubbay,
Dorothy J Denes,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Edmund F Mrak, Jr,
Emest F Bizjak,
Emmanuel J Ramos,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Frederick Razzaghi,
Helen B Ricalde,
Helen Verdel,
Jacqueline Mdiaz Albertini,
James A Liubicich,
Jean M Kelahan,
Jose M Cayuela,
Joseph F Mcginnis, RPh,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen E D'orazio,
Kelli F Dobilas,
Kevin P Foley,
Kinh Q Mac,
Ko U Min,
Kristy A Zielny,
Lata C Mathew, PhD,
Li Li,
Liatte Kreuger, PharmD,
Luis A Dasta,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Melba T Rivera,
Melba Trivera Clavell,
Meredith L Sheridan,
Meyer J Slobotsky,
Michael Serrano,
Mina D Ahmadi,
Monika Borkowska,
Nancy L Rolli,
Nancy M Espinal,
Nicholas A Violand,
Niketa Patel,
Niraj Mehta,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Regina T Brown,
Robin P Mathew,
Russell J Glapion,
Sandra Kershaw,
Shirley H Isbill,
Sidney B Priesmeyer,
Sinai Davis,
Stephen J Mottola,
Tara G Bizjak,
Tara R Gooen,
Thomas J Arista,
Wayne J Meyer
Sarah Adella Fave's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2000 | EIR | Hikma Injectables USA Inc. - EIR, 2000-04-12 |
April, 2000 | EIR | Cosmetic Essence Innovations - EIR, 2000-04-24 |
March, 2000 | EIR | Guardian Drug Company - EIR, 2000-03-30 |
February, 2000 | EIR | CorePharma, LLC - EIR, 2000-02-10 |
January, 2000 | FDA 483 | Med Prep Consulting, Inc. - Form 483, 2000-01-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more